Tag: CBIO

Home » CBIO

Despite New Rare Pediatric Disease Designation Catalyst Biosciences Inc. (CBIO) Continues to Slide

Gule Rukhsar January 26, 2022

On January 25, 2022, Catalyst Biosciences Inc. (CBIO) notified the reception of Rare Pediatric Disease Designation (RPDD) for CB 4332 for CFID treatment. Unaffected by

Catalyst Biosciences Inc. (CBIO) stock has surged in the current trading session; here’s why

ST Staff June 28, 2021

Catalyst Biosciences Inc. (CBIO) shares had surged in the current trading session by 5.29% mark to the price of $4.78 at which it traded at

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

Tag: CBIO

Despite New Rare Pediatric Disease Designation Catalyst Biosciences Inc. (CBIO) Continues to Slide

Catalyst Biosciences Inc. (CBIO) stock has surged in the current trading session; here’s why

Stocks
Telegraph

About

Categories

Social Links

Tag: CBIO

Despite New Rare Pediatric Disease Designation Catalyst Biosciences Inc. (CBIO) Continues to Slide

Catalyst Biosciences Inc. (CBIO) stock has surged in the current trading session; here’s why

Stocks Telegraph

About

Categories

Social Links

Stocks
Telegraph